Epigenomics AG (FRA:ECX)

Germany flag Germany · Delayed Price · Currency is EUR
1.200
-0.200 (-14.29%)
Feb 23, 2026, 8:09 AM CET
Market Cap1.23M +75.4%
Revenue (ttm)4.00K -97.1%
Net Income-2.76M
EPS-3.15
Shares Out876.95K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume664
Open1.200
Previous Close1.400
Day's Range1.200 - 1.200
52-Week Range0.500 - 1.590
Beta0.77
RSI61.12
Earnings DateMar 25, 2026

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is headquartered in Heidelberg, Germany. [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 1998
Employees 4
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ECX
Full Company Profile

Financial Performance

Financial Statements